299 related articles for article (PubMed ID: 29933751)
1. Alpha-fetoprotein-producing ovarian clear cell adenocarcinoma with fetal gut differentiation: a rare case report and literature review.
Chao WT; Liu CH; Lai CR; Chen YJ; Chuang CM; Wang PH
J Ovarian Res; 2018 Jun; 11(1):52. PubMed ID: 29933751
[TBL] [Abstract][Full Text] [Related]
2. Ovarian clear cell adenocarcinoma producing alpha-fetoprotein: case report.
Cetin A; Bahat Z; Cilesiz P; Demirbağ N; Yavuz E
Eur J Gynaecol Oncol; 2007; 28(3):241-4. PubMed ID: 17624099
[TBL] [Abstract][Full Text] [Related]
3. α-Fetoprotein-producing ovarian tumor in a postmenopausal woman with germ cell differentiation.
Meguro S; Yasuda M
Ann Diagn Pathol; 2013 Feb; 17(1):140-4. PubMed ID: 22056036
[TBL] [Abstract][Full Text] [Related]
4. SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma.
Ushiku T; Shinozaki A; Shibahara J; Iwasaki Y; Tateishi Y; Funata N; Fukayama M
Am J Surg Pathol; 2010 Apr; 34(4):533-40. PubMed ID: 20182341
[TBL] [Abstract][Full Text] [Related]
5. Oncofetal protein glypican-3 distinguishes yolk sac tumor from clear cell carcinoma of the ovary.
Esheba GE; Pate LL; Longacre TA
Am J Surg Pathol; 2008 Apr; 32(4):600-7. PubMed ID: 18277882
[TBL] [Abstract][Full Text] [Related]
6. The use of cytokeratin 7 and EMA in differentiating ovarian yolk sac tumors from endometrioid and clear cell carcinomas.
Ramalingam P; Malpica A; Silva EG; Gershenson DM; Liu JL; Deavers MT
Am J Surg Pathol; 2004 Nov; 28(11):1499-505. PubMed ID: 15489654
[TBL] [Abstract][Full Text] [Related]
7. Alpha-fetoprotein producing ovarian clear cell carcinoma with a neometaplasia to hepatoid carcinoma arising from endometriosis: a case report.
Takahashi Y; Mogami H; Hamada S; Urasaki K; Konishi I
J Obstet Gynaecol Res; 2011 Dec; 37(12):1842-6. PubMed ID: 21827573
[TBL] [Abstract][Full Text] [Related]
8. Ovarian malignant mixed germ cell tumor with clear cell carcinoma in a postmenopausal woman.
Yu XJ; Zhang L; Liu ZP; Shi YQ; Liu YX
Int J Clin Exp Pathol; 2014; 7(12):8996-9001. PubMed ID: 25674278
[TBL] [Abstract][Full Text] [Related]
9. Ovarian endometrioid adenocarcinoma with ectopic production of alpha-fetoprotein.
Maida Y; Kyo S; Takakura M; Kanaya T; Inoue M
Gynecol Oncol; 1998 Oct; 71(1):133-6. PubMed ID: 9784334
[TBL] [Abstract][Full Text] [Related]
10. SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma.
Cao D; Guo S; Allan RW; Molberg KH; Peng Y
Am J Surg Pathol; 2009 Jun; 33(6):894-904. PubMed ID: 19295406
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular oncofetal protein, glypican 3 is a sensitive marker for alpha-fetoprotein-producing gastric carcinoma.
Hishinuma M; Ohashi KI; Yamauchi N; Kashima T; Uozaki H; Ota S; Kodama T; Aburatani H; Fukayama M
Histopathology; 2006 Nov; 49(5):479-86. PubMed ID: 17064293
[TBL] [Abstract][Full Text] [Related]
12. Fetal gut-like differentiation in gallbladder cancer.
Koyama K; Maeda D; Tamura D; Narita C; Kudo-Asabe Y; Sato T; Yamamoto Y; Sageshima M; Nanjo H; Goto A
Hum Pathol; 2017 Dec; 70():27-34. PubMed ID: 28970139
[TBL] [Abstract][Full Text] [Related]
13. Alpha-fetoprotein (AFP)-producing epithelial ovarian carcinoma (EOC): a retrospective study of 27 cases.
Chen J; Wang J; Cao D; Yang J; Shen K; Huang H; Shi X
Arch Gynecol Obstet; 2021 Oct; 304(4):1043-1053. PubMed ID: 33751209
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of an early decline in serum alpha-fetoprotein during chemotherapy for ovarian yolk sac tumors.
de la Motte Rouge T; Pautier P; Genestie C; Rey A; Gouy S; Leary A; Haie-Meder C; Kerbrat P; Culine S; Fizazi K; Lhommé C
Gynecol Oncol; 2016 Sep; 142(3):452-7. PubMed ID: 27401840
[TBL] [Abstract][Full Text] [Related]
15. Glypican 3 has a higher sensitivity than alpha-fetoprotein for testicular and ovarian yolk sac tumour: immunohistochemical investigation with analysis of histological growth patterns.
Zynger DL; McCallum JC; Luan C; Chou PM; Yang XJ
Histopathology; 2010 May; 56(6):750-7. PubMed ID: 20546340
[TBL] [Abstract][Full Text] [Related]
16. Ovarian endometrioid tumors with yolk sac tumor component, an unusual form of ovarian neoplasm. Analysis of six cases.
Nogales FF; Bergeron C; Carvia RE; Alvaro T; Fulwood HR
Am J Surg Pathol; 1996 Sep; 20(9):1056-66. PubMed ID: 8764742
[TBL] [Abstract][Full Text] [Related]
17. Ovarian yolk sac tumors in older women arising from epithelial ovarian tumors or with no detectable epithelial component.
Roth LM; Talerman A; Levy T; Sukmanov O; Czernobilsky B
Int J Gynecol Pathol; 2011 Sep; 30(5):442-51. PubMed ID: 21804392
[TBL] [Abstract][Full Text] [Related]
18. A Report of Ovarian Sertoli-Leydig Cell Tumors With Heterologous Intestinal-type Glands and Alpha Fetoprotein Elevation and Review of the Literature.
Al-Hussaini M; Al-Othman Y; Hijazi E; McCluggage WG
Int J Gynecol Pathol; 2018 May; 37(3):275-283. PubMed ID: 28582340
[TBL] [Abstract][Full Text] [Related]
19. A case of ovarian serous adenocarcinoma suggestive of transformation to an AFP-producing tumor during chemotherapy.
Kataoka A; Nishida T; Sugiyama T; Yakushiji M
J Obstet Gynaecol (Tokyo 1995); 1995 Oct; 21(5):451-9. PubMed ID: 8542468
[TBL] [Abstract][Full Text] [Related]
20. Colorectal adenocarcinoma with enteroblastic differentiation: a clinicopathological study of five cases.
Murakami T; Yao T; Yatagai N; Yamashiro Y; Saito T; Sakamoto N; Nagahara A
Histopathology; 2020 Jan; 76(2):325-332. PubMed ID: 31429980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
